Skip to main content
. 2023 Feb 27;12(15):2202688. doi: 10.1002/adhm.202202688

Figure 2.

Figure 2

a) PEI‐g‐PEG/mRNA nanoparticles with various PEG terminal groups and PEG grafting ratios deliver mRNA to pulmonary immune cells. Adapted with permission.[ 28 ] Copyright 2020, American Chemical Society. b) Fine‐tuning of PBAE‐derived polymers with hydrophobic side chain and end‐cap allows for systemic mRNA delivery to the lung and the liver. Adapted with permission.[ 48a ] Copyright 2022, American Association for the Advancement of Science (AAAS).